广受欢迎的GLP-1减肥药与成瘾及药物过量风险降低相关

* *Draft:* 圣路易斯华盛顿大学医学院的研究人员发现，GLP-1药物与降低涉及酒精、尼古丁、大麻、可卡因、阿片类药物和其他物质的物质使用障碍的发展风险相关。对于已经患有成瘾症的人群，这些药物也与较少的过量用药、住院和药物相关死亡有关。 * *Refinement:* "Developing substance use disorders" -> 患上物质使用障碍. "Living with addiction" -> 患有成瘾症/患有成瘾疾病. "Associated with" -> 与...相关. * *Polished:* 圣路易斯华盛顿大学医学院的研究人员发现，GLP-1药物与降低涉及酒精、尼古丁、大麻、可卡因、阿片类药物及其他物质的物质使用障碍患病风险相关。对于已患有成瘾疾病的人群，这些药物还与过量用药、住院及药物相关死亡案例的减少有关。 * *Segment 2:* "The findings were published in *The BMJ*." * *Key terms:* *The BMJ* (《英国医学杂志》). * *Draft:* 这些发现发表在《英国医学杂志》上。 * *Polished:* 研究结果发表在《英国医学杂志》（*The BMJ*）上。 (Keeping the English name in brackets is standard for academic contexts, or just the Chinese name). Let's stick to standard Chinese translation: 研究结果发表在《英国医学杂志》上。 * *Segment 3:* "**GLP-1 Drugs and Addiction**" * *Draft:* **GLP-1药物与成瘾** * *Polished:* **GLP-1药物与成瘾** * *Segment 4:* "GLP-1 receptor agonists were originally developed to help manage type 2 diabetes, but their popularity has surged in recent years because of their effectiveness for weight loss. Along the way, researchers began noticing something unexpected." * *Key terms:* GLP-1 receptor agonists (GLP-1受体激动剂), type 2 diabetes (2型糖尿病), popularity has surged (普及率激增/大受欢迎), weight loss (减肥/减重). * *Draft:* GLP-1受体激动剂最初是为了帮助管理2型糖尿病而开发的，但近年来因其减肥效果而大受欢迎。在此过程中，研究人员开始注意到一些意想不到的事情。 * *Refinement:* "Manage" -> 管理/治疗. "Along the way" -> 在此过程中/随着研究的深入. * *Polished:* GLP-1受体激动剂最初是为辅助治疗2型糖尿病而研发的，但近年来因其显著的减重效果而迅速走红。在此过程中，研究人员开始注意到一些意想不到的现象。 * *Segment 5:* "Some patients reported losing interest in alcohol and cigarettes after starting the medications. Earlier observational studies also found links between GLP-1 treatment and lower risks of alcohol and cannabis use disorders, opioid overdose, and alcohol-related hospitalization." * *Key terms:* losing interest (失去兴趣), observational studies (观察性研究). * *Draft:* 一些患者报告在开始服药后对酒精和香烟失去了兴趣。早期的观察性研究也发现了GLP-1治疗与较低的酒精和大麻使用障碍、阿片类药物过量以及酒精相关住院风险之间的联系。 * *Polished:* 部分患者报告称，在开始用药后对酒精和香烟失去了兴趣。早期的观察性研究也发现，GLP-1治疗与较低的酒精和大麻使用障碍风险、阿片类药物过量风险以及酒精相关住院风险之间存在关联。 * *Segment 6:* "However, most previous studies focused on individual substances. Researchers wanted to determine whether the effects extended across multiple forms of addiction and whether the drugs could help reduce the most serious consequences associated with substance use disorders." * *Key terms:* individual substances (单一物质), multiple forms of addiction (多种成瘾形式), serious consequences (严重后果). * *Draft:* 然而，大多数以前的研究集中在单一物质上。研究人员想要确定这些效果是否延伸到多种成瘾形式，以及这些药物是否可以帮助减少与物质使用障碍相关的最严重后果。 * *Polished:* 然而，大多数先前的研究仅聚焦于单一物质。研究人员希望确定这些疗效是否适用于多种成瘾形式，以及这些药物是否有助于减少与物质使用障碍相关的最严重后果。 * *Segment 7:* ` ` (Keep as is or ignore? The prompt asks to translate the content. Usually, HTML tags are structural. I should probably keep the structure or just translate the text around it. The prompt says "translate the following content". I will output the text translation. If I need to keep the HTML structure, I will include the tags. Given the instruction "output translation result", preserving the structure is safer for web content.) -> *Decision: Keep HTML tags in place.* * *Segment 8:* "To investigate, the research team analyzed electronic health records from 606,434 U.S. veterans with type 2 diabetes." * *Key terms:* electronic health records (电子健康档案/病历), U.S. veterans (美国退伍军人). * *Draft:* 为了进行调查，研究团队分析了606,434名患有2型糖尿病的美国退伍军人的电子健康记录。 * *Polished:* 为了进行调查，研究团队分析了606,434名患有2型糖尿病的美国退伍军人的电子健康档案。 * *Segment 9:* "**Study Examines More Than 600,000 Veterans**" * *Draft:* **研究考察了超过60万名退伍军人** * *Polished:* **研究涵盖超过60万名退伍军人** * *Segment 10:* "Participants were divided into two groups. One group included people without a substance use disorder at the start of the study. The second group consisted of people who already had a diagnosed substance use disorder." * *Key terms:* diagnosed (确诊的). * *Draft:* 参与者被分为两组。一组包括在研究开始时没有物质使用障碍的人。第二组由已经确诊患有物质使用障碍的人组成。 * *Polished:* 参与者被分为两组。第一组包括研究开始时未患物质使用障碍的人群。第二组由已被确诊患有物质使用障碍的人群组成。 * *Segment 11:* "Researchers reviewed up to three years of health records after participants began taking either a GLP-1 receptor agonist, most commonly semaglutide, liraglutide, or dulaglutide, or an SGLT2 inhibitor, another type of diabetes medication." * *Key terms:* semaglutide (司美格鲁肽), liraglutide (利拉鲁肽), dulaglutide (度拉糖肽), SGLT2 inhibitor (SGLT2抑制剂). * *Draft:* 研究人员审查了参与者开始服用GLP-1受体激动剂（最常见的是司美格鲁肽、利拉鲁肽或度拉糖肽）或SGLT2抑制剂（另一种糖尿病药物）后长达三年的健康记录。 * *Polished:* 研究人员查阅了参与者开始服用GLP-1受体激动剂（最常见的是司美格鲁肽、利拉鲁肽或度拉糖肽）或SGLT2抑制剂（另一类糖尿病药物）后长达三年的健康档案。 * *Segment 12:* "Among the 524,817 participants who did not have a substance use disorder when the study began, those taking GLP-1 medications were less likely to develop one over time." * *Draft:* 在研究开始时没有物质使用障碍的524,817名参与者中，服用GLP-1药物的人随着时间的推移患病的可能性较小。 * *Polished:* 在研究开始时未患物质使用障碍的524,817名参与者中，服用GLP-1药物的人群随时间推移患病的可能性更低。 * *Segment 13:* "Compared with patients taking non-GLP-1 diabetes medications, GL * *Key terms:* GLP-1 use (GLP-1的使用), associated with (与...相关), fewer (减少), addiction-related emergencies (成瘾相关的紧急情况/急诊), serious health consequences (严重的健康后果). * *Draft:* 在该组中，GLP-1的使用与成瘾相关紧急情况和严重健康后果的减少有关。 * *Segment 2:* "After three years, participants taking GLP-1 drugs experienced a 30% reduction in emergency department visits, a 25% reduction in hospitalizations, a 40% reduction in overdoses, and a 50% reduction in drug-related deaths." * *Key terms:* After three years (三年后), participants taking GLP-1 drugs (服用GLP-1药物的参与者), reduction (减少), emergency department visits (急诊科就诊), hospitalizations (住院), overdoses (过量用药), drug-related deaths (药物相关死亡). * *Draft:* 三年后，服用GLP-1药物的参与者急诊科就诊减少了30%，住院减少了25%，过量用药减少了40%，药物相关死亡减少了50%。 * *Segment 3:* "Overall, the researchers estimated that GLP-1 use was associated with 12 fewer serious addiction-related events per 1,000 users." * *Key terms:* Overall (总体而言), estimated (估算), 12 fewer serious addiction-related events per 1,000 users (每1000名使用者减少12起严重的成瘾相关事件). * *Draft:* 总体而言，研究人员估算，GLP-1的使用与每1000名使用者减少12起严重成瘾相关事件有关。 * *Segment 4:* "'In addiction medicine, a lot of treatments target just one thing, for example, a nicotine patch helps with smoking, but not alcohol, but there is no medication that works across addictive substances, let alone all of them,' said senior author Ziyad Al-Aly, MD, a WashU Medicine clinical epidemiologist and Chief of the Research and Development Service at the VA Saint Louis Health Care System." * *Key terms:* Addiction medicine (成瘾医学), target just one thing (仅针对一种事物), nicotine patch (尼古丁贴片), works across addictive substances (对多种成瘾物质有效), let alone all of them (更不用说对所有物质都有效了). Senior author (资深作者), Ziyad Al-Aly, MD (医学博士Ziyad Al-Aly), WashU Medicine clinical epidemiologist (华盛顿大学医学院临床流行病学家), Chief of the Research and Development Service (研发主管), VA Saint Louis Health Care System (圣路易斯退伍军人医疗系统). * *Draft:* “在成瘾医学领域，许多治疗方法仅针对单一问题，例如，尼古丁贴片有助于戒烟，但对酒精无效，目前还没有一种药物能对多种成瘾物质起作用，更不用说对所有物质都有效了，”资深作者、华盛顿大学医学院临床流行病学家兼圣路易斯退伍军人医疗系统研发主管Ziyad Al-Aly医学博士说。 * *Segment 5:* "'The revelation about GLP-1 medication is that it really works against all major substances, and it works uniformly, not because it acts against alcohol or opioids or nicotine specifically, but because it is likely acting against the craving itself. It blunts that craving that pulls people toward whatever they're addicted to.'" * *Key terms:* Revelation (启示/发现), works against all major substances (对所有主要物质都有效), uniformly (一致地/普遍地), acts against (对抗/作用于), craving itself (渴望本身), blunts (减弱/钝化), pulls people toward (驱使人们趋向). * *Draft:* “关于GLP-1药物的启示在于，它确实对所有主要物质都有效，而且效果一致，这并不是因为它专门针对酒精、阿片类药物或尼古丁，而是因为它可能作用于渴望本身。它减弱了那种将人们拉向他们所成瘾事物的渴望。” * *Segment 6:* "Targeting the Biology of Craving" * *Key terms:* Targeting (针对/靶向), Biology of Craving (渴望的生物学机制). * *Draft:* **针对渴望的生物学机制** * *Segment 7:* "Al-Aly said the study was partly inspired by patient reports describing unexpected changes in behavior after starting GLP-1 treatment." * *Key terms:* partly inspired by (部分受...启发), patient reports (患者报告), unexpected changes in behavior (行为的意外变化). * *Draft:* Al-Aly表示，这项研究部分是受患者报告的启发，这些报告描述了开始GLP-1治疗后行为的意外变化。 * *Segment 8:* "Researchers also considered evidence showing that GLP-1 receptors are present in brain regions involved in reward processing." * *Key terms:* Evidence (证据), GLP-1 receptors (GLP-1受体), brain regions (脑区), reward processing (奖赏处理). * *Draft:* 研究人员还考虑了表明GLP-1受体存在于参与奖赏处理的脑区的证据。 * *Segment 9:* "That raised the possibility that the drugs could influence the cravings that drive addiction." * *Key terms:* Raised the possibility (提出了可能性/提示了可能性), influence (影响), cravings that drive addiction (驱动成瘾的渴望). * *Draft:* 这提出了该药物可能影响驱动成瘾的渴望的可能性。 * *Segment 10:* "The findings suggest that GLP-1 medications may act on a shared biological pathway underlying multiple forms of addiction." * *Key terms:* Findings (发现), act on (作用于), shared biological pathway (共同的生物学通路), underlying (构成...的基础), multiple forms of addiction (多种形式的成瘾). * *Draft:* 研究结果表明，GLP-1药物可能作用于多种成瘾形式背后的共同生物学通路。 * *Segment 11:* "Rather than targeting a specific substance, the drugs may be affecting the craving itself." * *Key terms:* Rather than (而不是), targeting a specific substance (针对特定物质), affecting the craving itself (影响渴望本身). * *Draft:* 这些药物可能并非针对特定物质，而是影响渴望本身。 * *Segment 12:* "The idea is particularly significant because some addictive substances, including methamphetamine, currently have no approved medication treatments." * *Key terms:* Particularly significant (尤为重要), methamphetamine (甲基苯丙胺/冰毒), approved medication treatments (获批的药物治疗). * *Draft:* 这一观点尤为重要，因为包括甲基苯丙胺在内的一些成瘾物质目前尚无获批的药物治疗。 * *Segment 13:* "'GLP-1s may offer a dual benefit for patients with chronic conditions like diabetes or obesity who are also struggling with a substance use disorder: one medication can treat both conditions at once,' Al-Aly said." * *Key terms:* Dual benefit (双重获益), chronic conditions (慢性疾病), diabetes (糖尿病), obesity (肥胖), substance use disorder (物质使用障碍), treat both conditions at once (同时治疗两种疾病). * *Draft:* “对于患有糖尿病或肥胖等慢性疾病且同时受物质使用障碍困扰的患者，GLP-1类药物可能提供双重获益：一种药物可以同时治疗这两种疾病，”Al-Aly说。 * *Segment 14:* "A Potential New Approach to Addiction Treatment" * *Draft:* **成瘾治疗的潜在新方法** * *Segment 15:* "Millions of Americans already use GLP-1 medications, and that number continues to grow." * *Draft:* 数百万美国人已经在使用GLP-1药物，且这一数字还在持续增长。 * *Segment 16:* "If future studies confirm these findings, the public health implications could be substantial." * *Key terms:* Public health implications (公共卫生意义/影响), substantial (巨大的/重大的). * *Draft:* 如果未来的研究证实了这些发现，其公共卫生意义可能是巨大的。 * *Segment 17:* "The researchers say the results support conducting clinical trials specifically designed to test GLP-1 drugs as addiction treatments, including studies capable of measuring effects on overdose and drug-related death." * *Key terms:* Support conducting clinical trials (支持开展临床试验), specifically designed (专门设计), measuring effects (测量效果). * *Draft:* 研究人员表示，这些结果支持开展专门设计用于测试GLP-1药物治疗成瘾的临床试验，包括能够测量对过量用药和药物相关死亡影响的研究。 * *Segment 18:* "'People taking these drugs for obesity often describe a quieting of 'food noise,' the persistent preoccupation with food that drives overeating,' Al-Aly said “我们的研究提示了更广泛的意义：GLP-1类药物可能也能平息我所谓的‘药物噪音’，即驱动跨物质成瘾的无休止渴求。这种跨物质信号指向了成瘾背后潜在的共同生物学基础，并为一种根本不同的治疗方法打开了大门：不再是一次仅治疗一种成瘾，而是靶向那种共同的生物信号，即跨越各种成瘾的共同渴求。从‘食物噪音’延伸至‘药物噪音’，GLP-1类药物正在平息成瘾的咆哮。” 该研究由美国退伍军人事务部资助。据作者所述，资助方在研究设计、数据收集、分析、解释、论文撰写、审查、批准或发表决策中未发挥任何作用。研究人员还指出，研究结果不代表退伍军人事务部或美国政府的观点。